Use of TXA to Prevent Postpartum Hemorrhage (TAPPH-1)
Prophylactic Use of Tranexamic Acid for Preventing Postpartum Hemorrhage: A Randomized, Double-blinded, Placebo-controlled Pilot Trial
Sponsor: Sunnybrook Health Sciences Centre
A PHASE2 clinical study on Post Partum Hemorrhage, this trial is ongoing. The trial is conducted by Sunnybrook Health Sciences Centre and has accumulated 12 data snapshots since 2018. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
12 versions recorded-
Oct 2024 — Present [monthly]
Unknown PHASE2
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Oct 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
Dec 2021 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Active Not Recruiting PHASE2
-
Mar 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Aug 2019 — Mar 2020 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Jun 2018 — Aug 2019 [monthly]
Recruiting PHASE2
-
Mar 2018 — Jun 2018 [monthly]
Recruiting PHASE2
Status: Not Yet Recruiting → Recruiting
-
Jun 2017 — Mar 2018 [monthly]
Not Yet Recruiting PHASE2
Phase: PHASE4 → PHASE2
-
May 2017 — Jun 2017 [monthly]
Not Yet Recruiting PHASE4
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Sunnybrook Health Sciences Centre
For direct contact, visit the study record on ClinicalTrials.gov .